Reversing memory deficits and impairments in spatial learning is a major goal in the field of dementia research. A lack of knowledge about cellular pathways critical to the development of dementia, however, has stood in the way of significant clinical advance. But now, researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) are breaking through that barrier. They show, for the first time in an animal model, that tau pathology – the second-most important lesion in the brain in patients with Alzheimer’s disease – can be reversed by a drug.
“We show that we can intervene after disease is established and pharmacologically rescue mice that have tau-induced memory deficits,” explained senior investigator Domenico Praticò, MD, Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple at LKSOM. The study, published online in the journal Molecular Neurobiology, raises new hope for human patients affected by dementia.
The researchers landed on their breakthrough after discovering that inflammatory molecules known as leukotrienes are deregulated in Alzheimer’s disease and related dementias. In experiments in animals, they found that the leukotriene pathway plays an especially important role in the later stages of disease.
“At the onset of dementia, leukotrienes attempt to protect nerve cells, but over the long term, they cause damage,” Dr. Praticò said. “Having discovered this, we wanted to know whether blocking leukotrienes could reverse the damage, whether we could do something to fix memory and learning impairments in mice having already abundant tau pathology.”
To recapitulate the clinical situation of dementia in humans, in which patients are already symptomatic by the time they are diagnosed, Dr. Praticò and colleagues used specially engineered tau transgenic mice, which develop tau pathology – characterized by neurofibrillary tangles, disrupted synapses (the junctions between neurons that allow them to communicate with one another), and declines in memory and learning ability – as they age. When the animals were 12 months old, the equivalent of age 60 in humans, they were treated with zileuton, a drug that inhibits leukotriene formation by blocking the 5-lipoxygenase enzyme.
After 16 weeks of treatment, animals were administered maze tests to assess their working memory and their spatial learning memory. Compared with untreated animals, tau mice that had received zileuton performed significantly better on the tests. Their superior performance suggested a successful reversal of memory deficiency.
To determine why this happened, the researchers first analyzed leukotriene levels. They found that treated tau mice experienced a 90-percent reduction in leukotrienes compared with untreated mice. In addition, levels of phosphorylated and insoluble tau, the form of the protein that is known to directly damage synapses, were 50 percent lower in treated animals. Microscopic examination revealed vast differences in synaptic integrity between the groups of mice. Whereas untreated animals had severe synaptic deterioration, the synapses of treated tau animals were indistinguishable from those of ordinary mice without the disease.
“Inflammation was completely gone from tau mice treated with the drug,” Dr. Praticò said. “The therapy shut down inflammatory processes in the brain, allowing the tau damage to be reversed.”
The study is especially exciting because zileuton is already approved by the Food and Drug Administration for the treatment of asthma. “Leukotrienes are in the lungs and the brain, but we now know that in addition to their functional role in asthma, they also have a functional role in dementia,” Dr. Praticò explained.
“This is an old drug for a new disease,” he added. “The research could soon be translated to the clinic, to human patients with Alzheimer’s disease.”
The Latest on: Dementia
via Google News
The Latest on: Dementia
- A Florida man stole nearly $20,000 from an elderly woman with dementia, police sayon November 19, 2019 at 12:53 pm
The victim's daughter told police that there have been numerous withdrawals from her mother's two bank accounts. Documents say she also stated that the 74-year-old has had "diagnoses of mild dementia ...
- Livonia police search for missing 68-year-old man with dementiaon November 19, 2019 at 12:48 pm
LIVONIA, Mich. – Livonia police are searching for a missing 68-year-old man who suffers from dementia. Phillilp Heilman was last seen around 6 a.m. Tuesday when he walked away from his home in the ...
- A 65-year-old woman suffering from dementia has gone missingon November 19, 2019 at 10:05 am
YORK COUNTY, S.C. — The York County Sheriff's Office is searching for a 65-year-old woman who is suffering from dementia. Deputies said the woman last seen at 3832 Wilson Chapel Rd. She is a white ...
- Takacs McGinnis Elder Care Law Hour: Watching Additional Therapies for Dementia and other Diseases: Music Therapyon November 18, 2019 at 4:26 pm
On today’s show, we’re learning more about therapies available for those living with dementia and other diseases.
- Research into the health effects of hearing loss suggests hearing aids might reduce dementia riskon November 18, 2019 at 11:00 am
Consumer Reports has no financial relationship with any advertisers on this site. For people with hearing loss, using a hearing aid is associated with a reduced risk of three common health problems of ...
- Message for dementia caregivers: You're not aloneon November 18, 2019 at 10:39 am
Message for dementia caregivers: You're not alone Caregivers receive relaxation exercises integrated with prayer and meditation; get guided practice in using assertive communication with family ...
- Half of older Americans fear that they’ll develop dementia — why most of their prevention methods are all wrongon November 18, 2019 at 10:02 am
Only 5.2% of respondents in a new study have actually talked with a doctor about steps they could take to reduce the risk of developing dementia. Nearly half (48.5%) of Americans in their 50s and ...
- Naperville seeking 'Dementia Friendly' statuson November 18, 2019 at 1:34 am
A new group in Naperville is looking for ways to support the estimated 30,000 DuPage County residents 65 and older who are affected by Alzheimer's disease or dementia. The Dementia Friendly Naperville ...
- What Science Tells Us About Preventing Dementiaon November 17, 2019 at 7:33 am
When it comes to battling dementia, the unfortunate news is this: Medications have proven ineffective at curing or stopping the disease and its most common form, Alzheimer’s disease. But that isn’t ...
via Bing News